NTRK1 and anaplastic large cell lymphoma: As a receptor tyrosine kinase of insulin receptor (IR) subfamily, anaplastic lymphoma kinase (ALK), has been validated to play important roles in various cancers, especially in non–small cell lung cancer (NSCLC) and anaplastic large cell lymphoma (ALCL).